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Abstract: Mediastinal masses are relatively uncommon, yet include 
a large variety of entities. Some tumors can be diagnosed with con-
fidence based on imaging alone; others when a typical appearance is 
combined with the right clinical presentation. A structured approach 
for radiologists is presented to facilitate evaluation of patients with 
anterior mediastinal tumors. The approach focuses first on the more 
common tumors and on imaging features that strongly suggest a par-
ticular diagnosis. Discussion with the clinician can be very helpful in 
formulating a presumptive diagnosis. This article also discusses that 
confirmatory imaging or biopsy tests are most beneficial in particular 
situations.
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Mediastinal masses are relatively uncommon. Furthermore, because there is such a wide variety of 
pathologic entities that can occur in this region, the average 
radiologist or clinician will encounter many of these specific 
lesions only infrequently. Imaging is a critical part of estab-
lishing a presumptive diagnosis, which will guide whether and 
what type of confirmatory testing is needed. When classic fea-
tures are present, a presumptive diagnosis can be made with a 
high degree of confidence based on imaging alone. However, 
the appearance of anterior mediastinal lesions is often less 
specific. Nevertheless, when combined with a typical clinical 
presentation, a particular entity can be strongly suggested.
Developing an appropriate differential diagnosis for 
a particular patient can be very useful in avoiding unneces-
sary and sometimes misleading biopsies or additional tests. 
A framework to guide the image interpretation and addi-
tional testing improves the efficiency of the evaluation. This 
is particularly pertinent since incidental anterior mediastinal 
abnormalities are discovered with increasing frequency due 
to increased imaging of asymptomatic patients, either for 
screening or staging of extrathoracic primary malignancies.1 
To address this need, the International Thymic Malignancy 
Interest Group (ITMIG) began an initiative to develop such 
a structured approach. This article represents the output of 
this project primarily addressed to radiologists; a companion 
paper focused on the clinician has also been produced.2
METHODS
The algorithm outlined in this document represents 
a consensus among radiologists and clinicians with a par-
ticular interest in anterior mediastinal diseases. The ITMIG 
Education Committee assembled a core workgroup (E.M.M., 
B.W.C., F.D., and M.O.) to review the existing literature as 
well as standards for imaging and clinical investigation of 
patients with an anterior mediastinal mass. This group drafted 
a proposed approach to the patient presenting with an ante-
rior mediastinal mass. The document was then refined by an 
extended workgroup (Ami Rubinowitz, Wentao Fang, Jeanne 
B. Ackman, and Stephen Cassivi).
GENERAL CONSIDERATIONS
Slightly more than half of all mediastinal masses are 
located in the anterior mediastinum. One-fourth of medias-
tinal masses are discovered in the middle mediastinum, and 
another one-fourth of masses are found in the posterior medi-
astinum.3–11 Assignment of lesions to particular mediastinal 
compartments has been quite useful in narrowing the dif-
ferential diagnosis. In the past, this classification was based 
on varying definitions based on the lateral chest radiograph. 
A modern, computed tomography (CT)-based definition of 
mediastinal compartments has been developed by ITMIG12 
building upon work done by radiologists associated with the 
Japanese Association for Research in the Thymus.13
INCIDENCE
The most common tumors of the anterior mediastinum 
include thymic malignancies and lymphoma, but the preva-
lence of the different abnormalities varies markedly according 
to both age and gender. Thymoma is the most common ante-
rior mediastinal mass and primary tumor of the anterior medi-
astinum, with the highest incidence in middle aged patients. 
Other tumors of the anterior mediastinum include benign 
teratomas and malignant germ cell tumors such as semino-
mas and nonseminomatous germ cell tumors (NSGCTs). 
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Malignant teratomas, which are residual lesions after treat-
ment of NSGCTs, are typically grouped in the same category 
as NSGCTs. Thymic cysts and benign cystic lesions (usually 
acquired, often related to surgery and radiation therapy) are 
among the most common nonneoplastic lesions of the anterior 
mediastinum. Additional nonneoplastic masses include vas-
cular abnormalities, substernal extension of thyroid goiters, 
other cystic lesions such as pericardial or bronchogenic cysts, 
and lesions related to infection such as tuberculosis.
The true incidence of anterior mediastinal masses is dif-
ficult to ascertain from the existing literature for numerous 
reasons. One of the most important of these is that different 
clinical and/or radiologic classification schemes have been 
used to define the mediastinal compartments. Additionally, the 
inclusion of nonneoplastic lesions such as thymic and pericar-
dial cysts differs between series. Finally, there is variability in 
the inclusion of lymphomas in different series. More detail on 
the relative incidence of anterior mediastinal tumors is pro-
vided elsewhere.2
ROLE OF IMAGING
A large anterior mediastinal mass is readily identified 
by chest radiography as it typically manifests as an extra soft 
tissue mass or opacity. The use of the silhouette sign, which 
describes the loss of normal borders of intrathoracic struc-
tures, increases the sensitivity of detecting mediastinal abnor-
malities. The borders of the anterior mediastinum, that is, the 
ascending aorta, right and left heart border, are visualized by 
radiography because they are delineated by natural contrast: 
the air containing lung (Figure 1A). The density of soft tis-
sue masses is similar to the anterior mediastinal structures 
and the image produced by the X-rays cannot differentiate 
between the abnormal mass and the normal mediastinal struc-
ture. However, since the mass displaces the air-containing 
lung from the normal mediastinal structure, the border of the 
normal mediastinal structure is lost. This loss of normal bor-
der is termed the silhouette sign (Figure 1B). However, the 
identification of a small mediastinal mass requires a more 
methodical approach. The presence of the anterior junction 
line, representing the point of contact between the anterior 
lungs and their pleural surfaces anterior to the cardiovascu-
lar structures, can help exclude the presence of an anterior 
mediastinal mass. This line is seen in 20% of normal chest 
radiographs (Figure 2A). Thickening of this line indicates an 
anterior mediastinal mass (Figure 2B).
Once an abnormality is identified by chest radiography, 
cross-sectional imaging is used to characterize the lesion, gen-
erate a differential diagnosis, assess for other abnormalities, 
and guide further management. CT with intravenous (IV) con-
trast has traditionally been the imaging modality of choice in 
the evaluation and characterization of an anterior mediastinal 
mass. One study analyzing 127 anterior mediastinal masses 
of various etiologies demonstrated that CT was equal or supe-
rior to magnetic resonance imaging (MRI) in the diagnosis of 
anterior mediastinal masses except for thymic cysts.14 Indeed, 
when a cystic mass is suspected or is to be investigated, MRI 
is the most useful imaging modality, because MRI is supe-
rior to CT in distinguishing cystic from solid masses (e.g., 
thymic cysts from thymic neoplasms), discerning cystic/
necrotic components within solid masses, and discerning thy-
mic hyperplasia from thymic tumors.15 For patients unable to 
undergo contrast-enhanced CT due to renal failure or allergy 
to IV contrast, non-contrast MRI may be performed to char-
acterize the lesion and evaluate for involvement of vascular 
structures. Chemical shift techniques used in MRI can also 
be used to differentiate thymic hyperplasia from thymoma 
in adult patients.16,17 18F-FDG positron emission tomography 
(PET)/CT is not routinely performed to evaluate or character-
ize an anterior mediastinal mass, but may be used to stage 
patients with specific malignant lesions and monitor response 
FIGURE 1.  Normal anatomy and the silhouette sign. A, Coned-down posteroanterior chest radiograph demonstrates the nor-
mal boundaries of the anterior mediastinum: the right heart border (white arrow), left heart border (black arrow), and ascend-
ing aorta (arrowheads). These structures are normally visible on chest radiography because they are delineated by air-filled lung. 
B, Coned-down posteroanterior chest radiograph of a different patient demonstrates obscuration of the right heart border and 
ascending aorta by a large right anterior mediastinal mass found to represent lymphoma at the time of surgery. This loss of nor-
mal boundaries and structures, known as the silhouette sign, may be used to localize an abnormality to a specific mediastinal 
compartment such as the anterior mediastinum in this case.
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to therapy and in some cases can help distinguish between cer-
tain malignancies. However, it is important to note that imag-
ing with FDG-PET can be misleading, given that normal and 
hyperplastic thymus and inflammatory lesions in the medias-
tinum are often FDG-avid.
IMAGING APPROACH TO AN ANTERIOR 
MEDIASTINAL MASS
Evaluation of an anterior mediastinal mass may seem 
difficult because of the number of different entities and the 
rarity with which most of them are encountered by the average 
radiologist. A discussion between the clinician and the radi-
ologist is exceedingly important, and it is best if this happens 
at the time the images are interpreted. The degree of confi-
dence in the presumptive diagnosis depends on how well it 
fits from a variety of viewpoints (imaging, demographics, and 
clinical presentation) and has significant bearing on the need 
for biopsy and if so, which type of biopsy approach is best.
To structure the approach to patients with an anterior 
mediastinal mass, we begin with identification of certain imag-
ing characteristics that allow a fairly certain diagnosis to be 
made on imaging alone. Then we discuss imaging features that 
are fairly common, and, while not definite by imaging appear-
ance alone, can nevertheless lead to a fairly reliable presump-
tive diagnosis in the appropriate clinical setting. We focus 
initially on the more commonly seen features and tumors, in 
order to present a practical way of structuring an approach 
to patients. Unusual tumors and features are discussed last; 
because of the rarity of such tumors the degree of certainly of 
the presumed diagnosis will always be somewhat limited.
A highly reliable clinical diagnosis of an anterior medi-
astinal lesion can be made when certain characteristic fea-
tures are found on cross-sectional imaging and/or are noted 
in the clinical presentation (Table 1). Specific findings such 
as hyperdense and enhancing lesions that communicate with 
the thyroid gland, intralesional fat, cystic components, and 
soft tissue attenuation may be used to narrow the differential 
diagnosis. The presence of calcifications, whether punctate, 
coarse, or curvilinear, cannot discriminate benign from malig-
nant anterior mediastinal masses and may be seen in a benign 
lesion (such as a benign teratoma) as well as in a malignant 
lesion (such as a thymoma or treated lymphoma).18
Lesions Identifiable on Imaging
A heterogeneous anterior mediastinal mass that is intrin-
sically hyperdense, enhances following the administration of IV 
contrast, and demonstrates continuity with the cervical thyroid 
gland can reliably be diagnosed as a mediastinal goiter. Most 
mediastinal goiters demonstrate high attenuation on non-con-
trast CT, with Hounsfield Units measuring 70–85, due to the 
presence of iodine (Figure 3A). Following the administration of 
IV contrast, prolonged and sustained enhancement is typically 
seen. Regions of low attenuation within goiters are commonly 
seen and represent cystic changes. Calcifications may also be 
present. The majority of substernal goiters can be reliably diag-
nosed by CT imaging alone. However, it is important to note 
that mediastinal goiters are not always connected to the thyroid 
gland; nevertheless, when they are separate, they often demon-
strate similar imaging features. As thyroid goiters may result 
in compression and deviation of the trachea, evaluation of the 
airways should be performed. When a goiter exhibits loss of 
distinct mediastinal fascial planes or is associated with cervi-
cal or mediastinal lymphadenopathy, the possibility of thyroid 
malignancy should be investigated.19 Although patients may be 
asymptomatic, symptoms related to compression of mediastinal 
structures (particularly the airways) should be reported.
The presence of visible areas of intralesional fat (which 
typically measures between ‒40 and ‒120 Hounsfield Units 
on CT) within a heterogeneous anterior mediastinal mass is 
highly suggestive of a benign teratoma, as these lesions char-
acteristically demonstrate varying amounts of fat, fluid, cal-
cification (including bone and tooth-like elements), and soft 
tissue.20,21 Fat is identified in approximately 50% of cases21 
(Figure 3B). Although a fat–fluid level is highly specific for 
teratoma, this finding is much less common, and formation 
of bone or a tooth is rare.22 Benign teratomas can sometimes 
be mostly cystic. Most benign teratomas are sufficiently char-
acteristic to be diagnosed reliably based on imaging charac-
teristics alone by an experienced thoracic radiologist. Benign 
teratomas are typically seen in younger patients and account 
for approximately 25% of anterior mediastinal masses in ages 
10–19, 10–15% in ages 20–49, and less than 5% over age 50 
in both men and women. Patients are typically asymptomatic, 
but may report symptoms due to compression of mediastinal 
structures.
FIGURE 2.  Normal and abnormal 
anterior junction line. A, Coned-down 
posteroanterior chest radiograph dem-
onstrates the normal anterior junction 
line (arrows), representing the point 
of contact between the anterior lungs 
and their pleural surfaces anterior 
to the cardiovascular structures. B, 
Coned-down posteroanterior chest 
radiograph of a different patient dem-
onstrates thickening of the anterior 
junction line (arrows) consistent with 
a biopsy-proven thymoma in the ante-
rior mediastinum.
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When well-circumscribed, round/oval/saccular, and 
homogeneous lesions are present in the anterior mediastinum 
near the thymic bed, the possibility of thymic cyst should be 
considered. Although thymic cysts may measure water or 
fluid attenuation (between 0 and 20 Hounsfield Units) on CT 
(Figure 3C), they can manifest as higher density lesions. This 
feature is responsible for CT’s inability to reliably distinguish 
cystic lesions from solid masses. In the case of suspected 
thymic cyst, MRI should be performed. Purely cystic lesions 
in the anterior mediastinum with no soft tissue nodules and 
TABLE 1.  Imaging Algorithm for Anterior Mediastinal Masses
A proposed structured approach for radiologists in evaluating patients with an anterior mediastinal mass. This table focuses on the most common entities first and on entities in 
which imaging is often particularly helpful. However, the incidence varies according to age and gender, and the level of confidence in a presumptive clinical diagnosis varies according 
to whether the radiographic features are seen with a congruent clinical setting.
aThis refers to which factors play a prominent role in establishing the presumptive clinical diagnosis.
“B” symptoms, fever, sweats, and weight loss; HD, Hodgkin disease; LB-NHL, lymphoblastic non-Hodgkin lymphoma; LDH, lactose dehydrogenase; MLC-NHL, mediastinal 
large cell non-Hodgkin lymphoma; MRI, magnetic resonance imaging; NSGCT, nonseminomatous germ cell tumor.
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no internal septations on MRI can reliably be diagnosed as 
unilocular thymic cysts.23 Cystic lesions that contain soft tis-
sue components may represent mulitlocular thymic cysts or 
cystic thymoma. The diagnosis of cystic thymoma should be 
strongly considered in patients with a cystic anterior mediasti-
nal lesion and symptoms related to myasthenia gravis or other 
paraneoplastic syndromes, especially men and women older 
than 40 years of age. A well-circumscribed lesion measuring 
water or fluid density with thin or imperceptible walls in one 
of the cardiophrenic angles can be confidently diagnosed as a 
pericardial cyst24,25 (Figure 3D).
Lesions Identifiable by a Combination 
of Imaging and Clinical Context
Normal thymic tissue is usually seen in young patients 
and should decrease in prominence with age. By age 40, the 
thymus should be replaced by fat. Thymic hyperplasia should 
be considered in young patients with uniform enlargement 
of the thymus compared with prior imaging, or in patients 
over the age of 40 with soft tissue in the thymic bed without 
focal mass or contour abnormality similar to normal thymus. 
In patients who have been treated with chemotherapy, radia-
tion therapy, or corticosteroids, have been exposed to stresses 
such as burns or injuries, or who have known disorders such 
as myasthenia gravis, hyperthyroidism, collagen vascular dis-
eases, or HIV, thymic hyperplasia should be considered when 
a low attenuation anterior mediastinal mass is identified. 
Although the most common manifestation of thymic hyper-
plasia is diffuse, symmetric enlargement of the thymus on 
CT, intralesional fat may be present and result in ill-defined 
regions of low attenuation (Figure 4A). In most patients, thy-
mic hyperplasia can be diagnosed reliably when there is a typ-
ical CT appearance (e.g., enlarged but maintaining the shape 
of the thymus) in a patient following stress. However, some-
times the CT appearance is not straightforward and it may 
appear more nodular or bulky in configuration, resembling a 
thymoma or lymphoma. When the findings are not classic for 
thymic hyperplasia, one can either re-image after a sufficiently 
long period (~3 months) to let the thymus decrease in size on 
its own or perform chemical shift MRI with in- and out-of-
phase gradient echo sequences. Thymic hyperplasia and the 
normal thymus demonstrate loss of signal on out-of-phase 
images due to the suppression of microscopic fat interspersed 
between nonneoplastic thymic tissue, whereas thymic malig-
nancies and lymphoma do not suppress on out-of-phase imag-
ing26,27 (Figure 4B–D). With either confirmatory approach an 
unnecessary biopsy or surgery can be avoided.
A homogeneous or slightly heterogeneous anterior 
mediastinal mass in men and women older than 40 years of 
age likely represents a thymoma28 (Figure 5A). When this 
appearance is combined with symptoms of myasthenia gra-
vis or other paraneoplastic syndrome (such as pure red cell 
FIGURE 3.  Lesions identifiable 
on imaging. A, Coronal reformat-
ted contrast-enhanced coned-down 
CT of an asymptomatic 54-year-old 
man demonstrates a high attenua-
tion and enhancing mass (M) in the 
anterior mediastinum that is con-
tiguous with the right lobe of the 
thyroid gland (arrow) and extends 
substernally, consistent with a goiter. 
Note the presence of coarse calcifica-
tions (arrowheads). B, Coned-down 
contrast-enhanced axial CT of an 
asymptomatic 34-year-old man dem-
onstrates a well-circumscribed mass 
(arrow) in the right anterior mediasti-
num that contains both fat (asterisk) 
and fluid. This appearance is highly 
suggestive of a benign teratoma. C, 
Coned-down contrast-enhanced axial 
CT of an asymptomatic 49-year-old 
woman demonstrates a well-defined 
mass (M) in the anterior mediastinum 
that is fluid attenuation. No soft tissue 
components or internal septations are 
present in this lesion, which represents 
a thymic cyst. D, Coned-down non-
contrast axial CT of an asymptomatic 
51-year-old man shows a lobular fluid 
attenuation mass (M) in the right 
cardiophrenic angle, consistent with a 
pericardial cyst.
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aplasia/Diamond-Blackfan syndrome or hypogammaglobu-
linemia), there is little doubt about the diagnosis. As more 
than 80% of thymomas are accurately diagnosed on CT or 
MRI due to their typical cross-sectional appearance, tissue 
diagnosis is typically unnecessary.14 Lymphadenopathy is 
typically absent, but pleural and/or pericardial spread may be 
identified in advanced (stage IV) disease and is often quite 
pathognomonic for thymic malignancy. In the setting of a 
large anterior mediastinal mass with features such as hetero-
geneity, local invasion, lymphadenopathy, and pleural effu-
sion, thymic epithelial neoplasms other than thymoma such 
as thymic carcinoma (Figure 5B) and carcinoid should be 
considered.29 On 18F-FDG PET/CT, thymic carcinomas and 
carcinoids typically demonstrate greater FDG uptake than 
thymomas.30,31
In patients with enlarged lymph nodes or lobulated soft 
tissue masses in the mediastinum on cross-sectional imaging, 
which may or may not be seen in association with lymph-
adenopathy in the lower neck or axilla, a lymphoma such 
as Hodgkin disease and mediastinal large cell non-Hodgkin 
lymphoma should be considered. Although it may be difficult 
to distinguish lymphoma from other soft tissue lesions in the 
mediastinum, the infiltrative nature of some lymphomas helps 
distinguish it from thymic epithelial neoplasms. Mediastinal 
lymphomas often encircle but “respect” the great vessels. 
When this is seen in the right age cohort, lymphoma being the 
most common anterior mediastinal mass in young patients, 
and especially when combined with “B” symptoms such as 
fever, weight loss, and night sweats (present in ~50% of medi-
astinal lymphomas), one can be quite confident of the clinical 
diagnosis. Further evaluation is typically performed with core 
needle biopsy combined with aspiration for flow cytometry or 
surgical biopsy.
For patients diagnosed with lymphoma, FDG-PET/CT 
has become the modality of choice for staging. FDG-PET/CT 
is more accurate than CT at detecting lymphomatous involve-
ment of lymph nodes, with a sensitivity of 94% and a specific-
ity of 100%, respectively, compared with 88% and 86% for 
CT.32 FDG-PET/CT is also effective at identifying intranodal 
and extranodal disease within the remainder of the body. The 
sensitivity and specificity of FDG-PET/CT in detecting organ 
involvement are 88% and 100%, respectively, compared with 
50% and 90% for CT.32
When patients present with a large anterior mediastinal 
mass, pleural effusion, “B” symptoms, and elevated serum lev-
els of lactate dehydrogenase, then lymphoblastic non-Hodgkin 
lymphoma should be considered (Figure 5C). A rapid onset 
of symptoms is characteristically seen. Cytology of the pleu-
ral effusion (when present) or bone marrow biopsy is almost 
always sufficient to confirm the presumptive diagnosis.
When a large, lobular homogeneous anterior mediasti-
nal mass is identified on cross-sectional imaging in a young 
man 10–39 years of age, seminoma should be considered33 
(Figure 5D). These lesions may be indistinguishable from 
FIGURE 4.  Thymic hyperplasia. A, 
Coned-down contrast-enhanced axial 
CT of a 23-year-old woman treated 
with chemotherapy for lymphoma 
demonstrates foci of low attenua-
tion within hyperplastic thymic tissue 
(arrow), consistent with thymic hyper-
plasia. B–D, Coned-down contrast-
enhanced axial CT (B) of a 38-year-old 
woman with chest pain and shortness 
of breath shows a soft tissue mass 
(arrow) in the anterior mediastinum. 
Because fat was difficult to detect by 
the CT alone to confirm the diagnosis 
of thymic hyperplasia, an MRI with 
chemical shift sequences was ordered. 
Axial in-phase (C) and out-of-phase (D) 
T1-weighted MRI of the same patient 
demonstrate soft tissue (arrow) in the 
anterior mediastinum that is similar in 
signal intensity to muscle on the in-
phase image but shows complete loss 
of signal intensity on the out-of-phase 
image, compatible with thymic hyper-
plasia. Thymic hyperplasia and normal 
thymus (as opposed to thymoma or 
other soft tissue masses in this region) 
demonstrate loss of signal on out-of-
phase imaging secondary to the sup-
pression of microscopic fat interspersed 
between normal thymic tissue.
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FIGURE 5.  Lesions identifiable on imaging with clinical context. A, Coned-down contrast-enhanced axial CT of a 43-year-old 
man with myasthenia gravis demonstrates a well-defined, lobular soft tissue mass (arrow) in the anterior mediastinum. In a 
patient older than 40 years of age, the imaging appearance and clinical history are typical of a thymoma, which was confirmed 
at the time of surgery. B, Coned-down contrast-enhanced axial CT of a 38-year-old with chest pain demonstrates a large, 
lobular mass (M) originating in the left anterior mediastinum. The central regions of low attenuation represent necrosis. Note 
the extension of tumor around the left heart with obliteration of the adjacent fat plane. CT-guided biopsy revealed thymic 
carcinoma and cardiac invasion was confirmed at the time of surgery. C, Coned-down contrast-enhanced axial CT of a 33-year-
old woman presenting with fever and weight loss demonstrates a large soft tissue mass (M) in the anterior mediastinum that 
extends into the middle mediastinum and insinuates itself around the great vessels. The infiltrative nature of this mass is char-
acteristic of lymphoma and enables differentiation from other anterior mediastinal masses, such as thymoma. D, Coned-down 
contrast-enhanced axial CT of a 37-year-old man presenting with chest pain demonstrates a large, homogeneous, lobular mass 
(M) in the anterior mediastinum. Elevated serum lactate dehydrogenase and slightly elevated serum β-HCG levels were present 
and seminoma was confirmed at biopsy. E, Coned-down contrast-enhanced axial CT of a 28-year-old man presenting with chest 
pain, weight loss, and elevated serum α-FP demonstrates a large heterogeneous mass (M) originating in the left anterior medi-
astinum and extending into the left hemithorax. Regions of low density represent tumor necrosis. Biopsy revealed NSGCT. Note 
the loculated left pleural effusion (E), which was found to represent metastatic disease to the left pleura at the time of surgery.
S117Copyright © 2014 by the International Association for the Study of Lung Cancer
Journal of Thoracic Oncology ®  •  Volume 9, Number 9, Supplement 2, September 2014 Anterior Mediastinal Mass: Radiographic Approach
lymphoma.33 Although pleural effusions are rare, pulmonary 
metastases are relatively common (this is distinctly unusual 
for Hodgkin disease or mediastinal large cell non-Hodgkin 
lymphoma). Approximately 10% of patients with seminoma 
demonstrate slightly elevated serum β-HCG but α-FP is typi-
cally normal.34,35 Serum lactate dehydrogenase levels are usu-
ally elevated, but this is true for many lymphomas as well.36,37 
Further evaluation with core needle or surgical biopsy is 
usually performed. When a heterogeneous anterior mediasti-
nal mass is present with lung metastases in women and men 
below the age of 40, NSGCTs should be included in the differ-
entiation diagnosis38,39 (Figure 5E). Markedly elevated serum 
α-FP or β-HCG levels are present in 90% of patients and are 
pathognomonic for this diagnosis.35,36,40,41 Primary mediastinal 
seminoma or NSGCTs are well-recognized entities; there is 
no documented reason to search for an occult testicular pri-
mary lesion via testicular ultrasound.
Evaluation of Rare Tumors
When an anterior mediastinal mass contains intral-
esional fat, several rare tumors can be clinically diagnosed 
with a high degree of confidence. In the setting of a large 
fat-containing mass in the anterior mediastinum or at one of 
the cardiophrenic angles, thymolipoma should be considered. 
These benign encapsulated lesions usually contain 50–85% fat 
(although up to 95% has been reported) and a small amount of 
solid tissue and fibrous septa, and are typically very large with 
an average size of 20 cm.42,43 Direct connection with the thy-
mus may be visualized and confirms the diagnosis.44 Patients 
may have symptoms related to mass effect such as dyspnea or 
be asymptomatic, and anecdotal cases of associations between 
thymolipomas and myasthenia gravis, Grave’s disease, and 
hematological disorders have been reported.44 Thymolipomas 
are relatively uncommon (<5% of anterior mediastinal masses 
in all age groups); but when they consist almost entirely of fat 
the diagnosis can be made quite reliably by imaging alone.
Additional rare tumors with intralesional fat include 
lipomas and liposarcomas. Lipomas account for approxi-
mately 2% of all primary mediastinal neoplasms and appear 
as encapsulated lesions primarily composed of fat with a 
small amount of soft tissue and vessels in the anterior medias-
tinum.45 Liposarcomas may be distinguished from lipomas by 
aggressive features such as increased soft tissue components, 
local invasion, lymphadenopathy, and metastatic disease.45,46 
Ectopic parathyroid adenomas may rarely occur in the medi-
astinum, typically in the anterior compartment. In one study, 
81% of these tumors were identified in the anterior medias-
tinum.47 Parathyroid adenomas manifest as small soft tissue 
lesions with or without calcification48; while this appearance 
is relatively nonspecific, these tumors should be suspected in 
the setting of hyperparathyroidism. Technetium-99 sestamibi 
single-photon emission computed tomography scans are typi-
cally more effective for making the diagnosis of ectopic para-
thyroid adenoma.48
Many anterior mediastinal masses may be reliably 
diagnosed by a combination of clinical and imaging features. 
However, when characteristic radiographic features are absent 
or seen in an atypical clinical setting, a presumptive diagnosis 
with reasonable confidence is not possible. In such scenarios, 
extensive speculation is usually not helpful; acquisition of tis-
sue through core needle, surgical biopsy, or resection is gener-
ally of greater benefit to guide subsequent management than 
additional imaging studies.
CONCLUSION
Certain anterior mediastinal tumors can be reliably iden-
tified by imaging alone, including substernal goiters, benign 
teratoma, and benign cysts. However, many anterior medias-
tinal tumors exhibit suggestive but inconclusive imaging fea-
tures; when the imaging correlates with the typical clinical 
features a presumptive diagnosis can be quite reliable. This 
underscores the need for a discussion between the clinician 
and the radiologist when evaluating most anterior mediastinal 
tumors. The suggested approach, therefore, is to initially rule 
in or out those lesions that can be reliably identified purely on 
the basis of characteristic imaging features. Less conclusive 
imaging features should be correlated with specific clinical 
features; in many cases this will strongly suggest a particu-
lar diagnosis and a further evaluative or treatment strategy. 
Additional detail regarding clinical features, evaluation and 
treatment is provided in the companion paper Approaching 
the Patient with an Anterior Mediastinal Mass: A Guide for 
Clinicians.2 This approach provides structure to the radiologic 
evaluation of anterior mediastinal masses, and facilitates a 
more streamlined and efficient discussion and further work-
up of these patients.
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